Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00943085 · ClinicalTrials.gov registry record · NA
Early Family-Focused Treatment for Youth at Risk for Bipolar Disorder
A NA study of Bipolar Disorder, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
- 2
- Study locations
NCT00943085: Completed NA study of Bipolar Disorder, sponsored by University of California, Los Angeles.
NCT00943085 is a NA study of Bipolar Disorder that has completed, run by University of California, Los Angeles. The registered enrollment target is 52 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (84% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00943085, a NA study of Bipolar Disorder, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will test a family-based therapy aimed at preventing or reducing the symptoms of bipolar disorder in at-risk children.
Conditions Studied
Interventions
- BEHAVIORAL Family-focused therapy
- BEHAVIORAL Brief educational treatment
Study Locations (2)
California
- Stanford University School of Medicine, Lucile Packard Children's Hospital - Stanford
Colorado
- University of Colorado, Boulder - Boulder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2007-04 |
| Est. Completion | 2011-08 |
| Phase | NA |
What the finished NCT00943085 record still lists
NCT00943085 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Bipolar Disorder appearing as the primary indexed condition, and to 2 interventions - of which Family-focused therapy is the first listed.
NCT00943085 reports a single indexed study location in California, Colorado.
Frequently Asked Questions
What is clinical trial NCT00943085 about?
NCT00943085 is a clinical study titled "Early Family-Focused Treatment for Youth at Risk for Bipolar Disorder". This study will test a family-based therapy aimed at preventing or reducing the symptoms of bipolar disorder in at-risk children.
What is the current status of trial NCT00943085?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2007-04. Estimated completion is 2011-08.
What conditions does trial NCT00943085 study?
This clinical trial studies the following conditions: Bipolar Disorder.
What interventions are being tested in trial NCT00943085?
The interventions under investigation include: Family-focused therapy (BEHAVIORAL), Brief educational treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT00943085?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00943085 being conducted?
This trial has 2 study locations across California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00943085's enrollment target sits among peer trials
52 105th of 162 higher than 56 of 162 other Bipolar Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bipolar Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Taking Action for College Students
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Intermittent Theta Burst Stimulation (iTBS) for Emotion Regulation in Bipolar Disorder
RECRUITING · NA
-
Healthy Lifestyles in Bipolar Disorder: Bay Area Study
RECRUITING · NA
-
A Future Thinking Intervention for Comorbid Tobacco Use Disorder and Bipolar Disorder
RECRUITING · NA
-
Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia